NIGERIA                               102 Yakubu Gowon Crescent     Telephone: (+234) 703 583 0641-4
THE WORLD BANK                        Asakoro District                         (+234) 708 999 6090-1
IBRD * IDA IwMkiBAMKrRouP             P.M.B. 339, Garki                       Fax: (+234) 9 314 5267
Abuta, FCT Nigeria
OFFICIAL
DOCUMENTS                     November 22, 2021
Mrs. Zainab S. Alumed
Honorable Minister of Finance, Budget and National Planning
Federal Ministry of Finance
Central Business District, Abuja, FCT
Dear Honorable Minister:
Re: NIGERIA: Nigeria COVJD-19 Preparedness and Response Project
Credit No. 6766-NG
Amendment to the Financing Agreement
We refer to the Financing Agreement between the Federal Republic of Nigeria (the "Recipient")
and the International Development Association (the "Association"), dated December 19, 2020, for the
Nigeria COVID-19 Preparedness and Response Project (the "Agreement"). We also refer to your letter of
May 18, 2021, requesting amendments to the Agreement. Please note that the capitalized terms used in
this letter ("Amendment Letter") and not defined herein have the meanings ascribed to them in the
Agreement.
In view of the above, the Association is pleased to amend the Agreement with respect to the
provisions below:
1.     Section 3.01 of the Agreement is hereby amended to read as follows:
"3.01. The Recipient declares its commitment td the objectives of the Project. To this end, the
Recipient shall, cause: (i) NCDC to carry out the Project; (ii) NPHCDA to carry out Parts
1(c) and 1(d) of the Project; and (iii) the Participating States to carry out Parts 1(b) and
1(d) of the Project, all in accordance with the provisions of Article V of the
General Conditions and Schedule 2 to this Agreement."
2.     Paragraphs (c) and (d) arehereby added to Part 1 of Schedule 1 to the Agreementto read as Follows:
"(c)   Vaccine Acquisition
Support the Recipient in the purchase of Project COVID-19 Vaccine, including the use
of advance purchase mechanisms and related costs.
(d)    Vaccine Deployment
Deployment of Project COVID- 19 Vaccine atthe subnational levels through, inter clia:
(i) the development of micro-plans for vaccination; (ii) training and retraining of health
workers on microplanning and vaccine implementation; (iii) advocacy communication
and social mobilization; (iv) monitoring and supervision of vaccination,
pharmacovigilance; (v) adverse effects following immunization (AEFI) kits and data
tools; (vi) financing personnel involved in deployment of vaccines; (vii) procurement
of cold boxes, carriers and FPE for vaccination teams; and (viii) transport and logistics
costs for Project COVID-19 Vaccine"


Mrs. Zainab S. Ahmoed                        2 -                        November 22, 2021
3.     Section L.A.1.l1. of Schedule 2 to the Agreement is hereby amended to read as follows:
"11.   The Recipient, acting through the Federal Ministry of Health, shall cause NCDC to
lead, coordinate, and oversee overall implementation of the Project, and shall cause
NPHCDA to carry out Parts 1(c) and 1(d) of the Project, all in accordance with the
provisions of this Agreement."
4.     Section I.A.I.1.2 of Schedule 2 to the Agreement is hereby amended to read as follows:
1.2    National Steering Committee
(a)    The Recipient shall, no later than one (1) month after the Effective Date,
establish and thereafter maintain throughout the Project implementation a National
Steering Committee at federal level ("NSC") with functions, composition, and
resources satisfactory to the Association.
(b)    Without limitation to the provisions of sub-paragraph (a) above, the NSC shall
be chaired by the Honorable Minister of Health, and include as members the Honorable
Minister of Finance, Budget and National Planning (FMoFBNP), the Permanent
Secretary of the Federal Ministry of Health, the Director of Public Health and the
Director Planning, Research and Statistics of the Federal Ministry of Health, the
Director of International Economic Relations Department (IERD) of the FMoFBNP,
Technical Lead of the PSC, the Director General of the NCDC, the Chief Executive of
the NPHCDA, the Chief Executive of the NHIS, and a representative of the Governors
of the Participating States, and representatives of the Commissioners of Nigeria Health
Forum, with representatives of development partners to be invited as observers when
appropriate, as may be further specified in the PIM.
(c)    Without limitation to the provisions of sub-paragraph (a) above, the NSC shall
be responsible for overall Project direction and achievement of the project development
objective, approving the eligibility criteria for disbursement to Participating States
under the Subsidiary Agreement, and approving Annual Work Plans and Budgets
(including the IAPs of Participating States) and the PIM on the recommendation of the
NTC, all as may be further specified in the PIM.
5.     Paragraph (c) of Section A..1.3 of Schedule 2 to the Agreement is hereby amended to read as
follows:
(c)    Without limitation to the provisions of sub-paragraph (a) above, the NTC shall be
responsible for, inter alia: (i) overseeing the planning, management and monitoring of
Project activities, including policy issues; (ii) review and recommend for the approval
of the NSC the TAPs of Participating States and the Annual Work Plan and Budget; (iii)
ensure timely implementation of the project by the PCU; and (iv) review progress
reports prepared by the PCU to ensure agreed performance targets and timelines for
activities of the project are met, and all as further specified in the PIM.
6.     Paragraph (b) of Section A.2.2.1 of Schedule 2 to the Agreement is hereby amended to read as
follows:
(b)    Without limitation to the provisions of sub-paragraph (a) above, each SPSC shall be
chaired by the Commissioner of the State Ministry of Health, and include as members
a representative of the State Task Force on COVID-19, state commissioners for
finance, budget and planning, water resources and information, the Permanent


Mrs. Zainab S. Ahmed                      - 3 -                     November 22, 2021
Secretary of Health, the Director of Public Health and the Director Planning, Research
and Statistics of the State Ministry of Health, and such other members as may be
detailed in the PIM.
7.     Sections I.B.1 of Schedule 2 to the Agreement is hereby amended to read as follows:
"1.    To facilitate the carrying out of Parts 1(b) and (d) of the Project, the Recipient shall
make a portion of the proceeds of the Financing available to each Participating State
on an imprest basis under a Subsidiary Agreement entered into between the Recipient
and the Participating State detailing the arrangements for the implementation of said
Part under the relevant approved State Incident Action Plan and the disbursement of
such proceeds to, and their use by, the Participating State."
8.     Section I.B.2(b) of Schedule 2 to the Agreement is hereby amended to read as follows:
"(b)   the requirement that the Participating State carry out Parts 1(b) and (d) of the Project
with due diligence and efficiency, in conformity with administrative, financial
management, engineering, technical, environmental and social practices and
arrangements (including the ESS and the ESCP), and provide, or cause to be provided,
promptly as needed, the facilities, services and other resources required for the
Project;"
9.     Section IC of Schedule 2 to the Agreement is hereby amended to read as follows:
"C.    Project Implementation Manual
1 .    No later than one month after the Effective Date of the Additional Financing
Agreement, in order to ensure adequate implementation of Parts 1(c) and 1(d) of the
Project, the Recipient shall furmish to the Association for review, the Project
implementation manual, which shall include provisions on the following matters:
(a)    institutional arrangements for the oversight, coordination, management and
day-to-day implementation of the Project, including details on the respective
roles and responsibilities of the entities set out in Section A of this Schedule 2,
as well as coordination arrangements with NPHCDA for the implementation
of Parts 1(c) and 1(d) of the Project;
(b)    financial management;
(c)    procurement, including the retroactive financing of advance procurement;
(d)    COVID-19 Vaccine delivery and deployment, as set forth in Section 2 below;
(e)    arrangements for preventing, detecting, reporting, investigation, remediation
and otherwise addressing fraud and corruption, including compliance with the
Anti-Corruption Guidelines;
(f)    environmental and social management systems, including on grievance
redressal mechanism, gender-based violence and sexual exploitation and abuse
(GBV/SEA);
(g)    collection and processing of Personal Data in accordance with good
international practice;
(h)    security risk mitigation measures;


Mrs. Zainab S. Ahmed                       -4 -                        November 22, 2021
(i)    monitoring and evaluation, reporting and communication;
(j)    disbursement and flow of funds arrangements, including conditions for
disbursement to Participating States under their respective Subsidiary
Agreements; and
(k)    such other administrative, financial, technical and organizational arrangements
and procedures as shall be required for the Project.
2,     Without limitation on Section 1 above, the PIM shall include a section or annex on
COVID- 19 Vaccine delivery including:
(a)    rules and procedures for prioritizing intra-country vaccine allocation following
principles established in the WH-O Fair Allocation Framework, including an
action plan setting out the timeline and steps for implementing such rules;
(b)    rules and procedures establishing minimum standards for vaccine management
and monitoring, including medical and technical criteria, communications and
outreach plan, cold chain infrastructure, and other related logistics
infrastructure;
(c)    rules and procedures for processing and collection of Personal Data in
accordance with good international practice; and
(d)    vaccine distribution plan, including action plan setting out timeline and steps
for immunization;
3.     The Recipient shall afford the Association a reasonable opportunity to exchange views
with the Recipient on the Project implementation manual, and thereafter, shall adopt
the Project implementation manual, in such form as shall have been approved by the
Association ("Project Implementation Manual" or "PIM").
4.     The Recipient shall ensure that the Project is carried out in accordance with the PIM;
provided, however, that in case of any conflict between the provisions of the PIM and
the provisions of this Agreement, the provisions of this Agreement shall prevail.
5.     Except as the Association shall otherwise agree, the Recipient shall not anmend,
abrogate or waive any provision of the PIM."
10.    A new Section I.E.6 is hereby added to Schedule 2 to the Agreement to read as follows:
"6.    The Recipient shall ensure that all bidding documents and contracts for civil works
under the Project include the obligation of contractors, subcontractors and supervising
entities to: (a) comply with the relevant aspects of ESCP and the environmental and
social instruments referred to therein; and (b) adopt and enforce codes of conduct that
should be provided to and signed by all workers, detailing measures to address
environmental, social, health and safety risks, and the risks of sexual exploitation and
abuse, sexual harassment and violence against children, all as applicable to such civil
works commissioned or carried out pursuant to said contracts."


Mrs. Zainab S. Ahmed                       - 5 -                      November 22, 2021
11.    Sections LF and LG are hereby added to Schedule 2 to the Agreement to read as follows:
"F.    Use of Military and Security Actors
1.     The Recipient, acting through the NPHCDA, the Nigeria Police Force or the Nigeria
Security and Civil Defence Corps, as the case shall be, shall take the following
measures related to the use of personnel to provide security for the implementation of
Project activities, in a manner satisfactory to the Association:
(a)    Adopt and enforce standards, protocols and codes of conduct for the selection
and use of security or military personnel, and screen such personnel to verify
that they have not engaged in past unlawful or abusive behavior, including
sexual exploitation and abuse (SEA), sexual harassment (SH) or excessive use
of force;
(b)    ensure that NPHCDA enters into memorandum of understanding (MoU), with
the, the Nigeria Police Force and the Nigeria Security and Civil Defence Corps,
setting out the arrangements for the engagement of the security personnel
under the Project, including compliance with the relevant requirements of the
ESCP;
(c)    ensure that such personnel is deployed in accordance with the relevant
requirements of ESSs and the ESCP;
(d)    ensure that such personnel is adequately instructed and trained, prior to
deployment and on a regular basis, on the use of force and appropriate conduct
(including in relation to civilian-military engagement, SEA and SH, and other
relevant areas), as set out in the Project Implementation Manual, ESMF,
Security Management Plan, and the above-mentioned MoU; and
(e)    ensure that the stakeholder engagement activities under the Stakeholder
Engagement Plan include a communication strategy on the involvement of
security personnel under the Project;
(f)    ensure that any concerns or grievances regarding the conduct of such personnel
are received, monitored, documented (taking into account the need to protect
confidentiality), resolved through the Project's grievance mechanism; and
reported to the Association no later than 30 days after being received; and
(g)    where the Association shall require, after consultation with the Recipient:
(i) promptly appoint a TPM Consultant, with terms ofreference, qualifications
and experience satisfactory to the Association, to visit and monitor the Project
area where military, paramilitary or security personnel]are deployed, collect
relevant data and communicate with Project stakeholders and beneficiaries; (ii)
require the TPM Consultant to prepare and submit monitoring reports, which
shall be promptly made available to and discussed with the Association; and
(iii) promptly take any actions, as may be requested by the Association upon
its review of the TPM Consultant's reports.
2.     For the avoidance of doubt, and without limitation upon the Recipient's other
obligations under this Agreement, the Recipient further undertakes that no Financing
proceeds or resources may be used for payments to the Nigeria Police Force or the
Nigeria Security and Civil Defence Corps, or any other law-enforcement, security,


Mrs. Zainab S. Ahmed                       - 6 -                      November 22, 2021
military, or paramilitary purposes or for any payments made to any law-enforcement,
security, military, or paramilitary forces.
G.     Standards for COVID-19 Vaccine Approval
All Project COVID-19 Vaccines shall satisfy the Vaccine Approval Criteria."
12.    The Expenditures table as set forth in Section III.A. of Schedule 2 to the Agreement is hereby
amended and replaced with the table shown in the Annex to this Amendment Letter.
13.    Section III.B.1 (b) of Schedule 2 to the Agreement is hereby amended to read as follows:
"(b)   under Category (4) for payments to any Participating State, unless and until such
Participating State has: (i) submitted a work plan and budget for the deployment of
COVID- 19 Vaccines to NTC, and said work plan and budget has been approved by the
NTC, with the no objection of the Association; and (ii) signed a Subsidiary Agreement
with the Recipient, acceptable to the Association, for purposes of implementing Parts
1(b) and 1(d) of the Project in accordance with Section I.B of Schedule 2 to this
Agreement."
14.    Section III.B.2. of Schedule 2 to the Agreement is hereby amended to read as follows:
"2.    The closing date is February 29, 2024.
15.    A new Section IV is hereby added to Schedule 2 to the Agreement to read as follows:
"Section Irv. Other Undertakings
1.     Without limitation to the provisions of Section I.A.1.3 of this Schedule 2, the Recipient
shall engage, no later than sixty (60) days after the Effectiveness Date, technical staff
for the PCO, in such numbers and with such qualifications and terms of reference as
may be acceptable to the Association, to enable the PCU to oversee the implementation
of both the Project (including, without limitation, the deployment of COVID-19
Vaccines) and REDISSE."
16.    Paragraph 14 of the Definitions Section of the Appendix to the Agreement is hereby amended to
read as follows:
"14.   "NPHCDA" means the National Primary Health Care Development Agency,
established as a parastatal by Decree No. 29 on the 26th of June, 1992, under the
supervision of the Federal Ministry of Health, as the federal government body with
mandate to control preventable diseases, improve access to basic health services and
improve quality of care."
17.    The following new definitions are hereby added and placed in alphabetical order in the Definitions
Section of the Appendix to the Agreement to read as follows and the rest of the definitions are
renumbered accordingly to maintain alphabetical order:
""Additional Financing Agreement" means the financing agreement to be entered between the
Recipient and the Association for the Nigeria COVID-1 9 Preparedness and Response Project."
"'COVAX Facility" means the COVID-19 Vaccine Global Access Facility, a mechanism
through which demand and resources are pooled to support the availability of, and equitable
access to, COVID-19 vaccines for all economies, and which is coordinated by Gavi, the
Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations (CEPI), and the WHO."


Mrs. Zainab S. Ahmed                       - 7 -                      November 22, 2021
'"'Nigeria Security and Civil Defence Corps" means the institution of said name established
by the Nigeria Security and Civil Defence Corps Act 2003, Act No. 2 of 2003, and amended
by the Nigeria Security and Civil Defence Corps (Amendment) Act 2007, Act No. 6 of 2007,
for the purpose of assisting in the maintenance of peace and order and in the protection and
rescuing of the Recipient's civil population during the period of emergency."
"'Nigeria Police Force" means the Recipient's principal law enforcement agency, established
under Section 214 of the 1999 Nigerian Constitution."
""Project COVID-19 Vaccine" means a vaccine for the prevention of COVID-19, authorized
by the Recipient's national regulatory authority for distribution, marketing and administration
within the territory of the Recipient, and acquired or deployed under the Project; "Project
COVID-19 Vaccines" means the plural thereof."
""Stringent Regulatory Authority" means a National Regulatory Authority ("NRA") that is
classified by WHO as a Stringent Regulatory Authority."
""TPM Consultant" means the third-party monitoring consultant responsible for monitoring the
Project activities undertaken by NCDC, the Nigeria Police Force and the Nigeria Civil Defence
Corps to monitor civilian-military engagement and compliance with applicable laws and
regulations in accordance with the relevant terms of reference approved by the Association."
""Vaccine Approval Criteria" means that the Project COVID-19 Vaccine: (a) has received
regular or emergency licensure or authorization from at least one of the Stringent Regulatory
Authorities identified by WHO for vaccines procured and/or supplied under the COVAX
Facility, as may be amended from time to time by WHO; (b) has received the WHO
Prequalification or WHO Emergency Use Listing; or (c) has met such other criteria as may be
agreed in writing between the Recipient and the Association."
""WHO Emergency Use Listing" means a risk-based procedure for assessing and listing by
WHO of unlicensed vaccines, therapeutics, and in vitro diagnostics with the aim of expediting
the availability of these products to people affected by a declared public health emergency."
""WHO Fair Allocation Framework" means the rules which govem the allocation of vaccines
to participants in the COVAX Facility, as developed by WTHO, subject to periodic review by
the COVAX Facility."
""WHO Prequalification" means a service provided by WHO to assess the quality, safety, and
efficacy of medical products for priority diseases, and which are intended for United Nations
and international procurement to developing countries."
All other provisions of the Agreements that have not been amended hereby, shall remain in full
force and effect.


Mrs. Zainab S. Ahmed                     - 8 -                      November 22, 2021
Please indicate your agreement with the foregoing amendments to the Agreements on behalf of
the Recipient by countersigning and dating this Amendment Letter. This Amendment Letter shall
become effective as of the date of countersignature.
Very truly yours,
INTERNATIONAL BANK FOR RECONSTRUCTION AND DEVELOPMENT
INTERNATIONAL DEVELOPMENT ASSOCIATION
By:
Shubbam Chaudhuri
Country Director, Nigeria
Western and Central Africa Region
AGREED:
FEDERAL REPUBLIC OF NIGERIA
By:         uthorizDate: Repr [e(s
Authorized Representative
Name: P\(S:. C/ 0   &rv       K   At,)u
Title:  L1 '~ \&iH     c-k     X1 .~,      &c&c bf?cft           /


Mrs. Zainab S. Ahmed                     - 9-                       November 22, 2021
Annex
Percentage of
Amount of the Credit      Expenditures to be
Allocated (expressed in        Financed
"Category                        SIDR)             (inclusive of Taxes)
(1) Goods, works, non-consulting                        0             100%
services, consulting services,
Training and Operating Costs for
Parts 1(a) and Part 2 the Project, as
of May 18, 2021
(2) Goods, works, non-consultation                      0             100%
services, consulting services,
Training and Operation Costs for
Part 1(b) of the Project, as of May
18, 2021.
(1) Goods, works, non-consulting                 7,270,000            100%
services, consulting services,
Training and Operating Costs for
Parts 1(a) and Part 2 the Project
(2) Goods, works, non-consultation              65,430,000            100%
services, consulting services,
Training and Operation Costs for
Parts 1(b) and 1(d) of the Project
TOTAL AMOUNT                                   72,700,000"